Intrahepatic CCA |
Chronic thioacetamide (TAA) administration |
Rosa26-LSL-LacZ mice crossed with AlbuminCreERT mice or K19CreERT mice |
Hepatocytes |
Hepatocyte-specific activation of Akt and Notch pathways by hydrodynamic tail vein injection |
Injection of adenoassociated virus serotype 8 vector expressing Cre from transthyretin promoter into Rosa26-LSL-EYFP mice |
Hepatocytes |
Duct cell-specific Kras activation and PTEN deletion |
K19CreERT mice crossed with LSL-KrasG12D mice and Ptenflox/flox mice |
Cholangiocytes |
Duct cell-specific p53 deletion in combination with chronic TAA administration |
K19CreERT mice crossed with p53flox/flox mice and Rosa26-LSL-EYFP mice |
Cholangiocytes |
Extrahepatic CCA |
Duct cell-specific activation of Kras and deletion of TGFβR2 and E-cadherin |
K19CreERT mice crossed with LSL-KrasG12D, Tgfbr2flox/flox, CDH1flox/flox, and Rosa26-LSL-LacZ mice |
Peribiliary glands (PBGs) |